Literature DB >> 24175722

Chronic pain treatment with opioid analgesics: benefits versus harms of long-term therapy.

Nalini Sehgal1, James Colson, Howard S Smith.   

Abstract

Chronic non-cancer pain (CNCP) is a disabling chronic condition with a high prevalence rate around the world. Opioids are routinely prescribed for treatment of chronic pain (CP). In the past two decades there has been a massive increase in the number of opioid prescriptions, prescribed daily opioid doses and overall opioid availability. Many more patients with CNCP receive high doses of long-acting opioids on a long-term basis. Yet CP and related disability rates remain high, and majority of the patients with CNCP are dissatisfied with their treatments. Intersecting with the upward trajectory in opioid use are the increasing trends in opioid related adverse effects, especially prescription drug abuse, addiction and overdose deaths. This complex situation raises questions on the relevance of opioid therapy in the treatment of CNCP. This article reviews current evidence on opioid effectiveness, the benefits and harms of long-term therapy in CNCP.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24175722     DOI: 10.1586/14737175.2013.846517

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN: 1473-7175            Impact factor:   4.618


  24 in total

1.  Gender and nonmedical prescription opioid use and DSM-5 nonmedical prescription opioid use disorder: Results from the National Epidemiologic Survey on Alcohol and Related Conditions - III.

Authors:  Bradley T Kerridge; Tulshi D Saha; S Patricia Chou; Haitao Zhang; Jeesun Jung; W June Ruan; Sharon M Smith; Boji Huang; Deborah S Hasin
Journal:  Drug Alcohol Depend       Date:  2015-09-02       Impact factor: 4.492

2.  In vitro and in vivo characterization of the bifunctional μ and δ opioid receptor ligand UFP-505.

Authors:  N Dietis; H Niwa; R Tose; J McDonald; V Ruggieri; M Filaferro; G Vitale; L Micheli; C Ghelardini; S Salvadori; G Calo; R Guerrini; D J Rowbotham; D G Lambert
Journal:  Br J Pharmacol       Date:  2018-05-14       Impact factor: 8.739

Review 3.  Targeting AMPK for the Alleviation of Pathological Pain.

Authors:  Marina N Asiedu; Gregory Dussor; Theodore J Price
Journal:  Exp Suppl       Date:  2016

Review 4.  Characterizing the Interrelationships of Prescription Opioid and Benzodiazepine Drugs With Worker Health and Workplace Hazards.

Authors:  Michele Kowalski-McGraw; Judith Green-McKenzie; Sudha P Pandalai; Paul A Schulte
Journal:  J Occup Environ Med       Date:  2017-11       Impact factor: 2.162

Review 5.  Optimal pain management for patients with cancer in the modern era.

Authors:  Bethann M Scarborough; Cardinale B Smith
Journal:  CA Cancer J Clin       Date:  2018-03-30       Impact factor: 508.702

Review 6.  Opioids and bariatric surgery: A review and suggested recommendations for assessment and risk reduction.

Authors:  Leslie J Heinberg; Lauren Pudalov; Hanan Alameddin; Kristine Steffen
Journal:  Surg Obes Relat Dis       Date:  2018-11-23       Impact factor: 4.734

7.  Clinically Inconsequential Alerts: The Characteristics of Opioid Drug Alerts and Their Utility in Preventing Adverse Drug Events in the Emergency Department.

Authors:  Emma K Genco; Jeri E Forster; Hanna Flaten; Foster Goss; Kennon J Heard; Jason Hoppe; Andrew A Monte
Journal:  Ann Emerg Med       Date:  2015-11-06       Impact factor: 5.721

8.  The burden of premature opioid-related mortality.

Authors:  Tara Gomes; Muhammad M Mamdani; Irfan A Dhalla; Stephen Cornish; J Michael Paterson; David N Juurlink
Journal:  Addiction       Date:  2014-07-07       Impact factor: 6.526

9.  The PREEMPT study - evaluating smartphone-assisted n-of-1 trials in patients with chronic pain: study protocol for a randomized controlled trial.

Authors:  Colin Barr; Maria Marois; Ida Sim; Christopher H Schmid; Barth Wilsey; Deborah Ward; Naihua Duan; Ron D Hays; Joshua Selsky; Joseph Servadio; Marc Schwartz; Clyde Dsouza; Navjot Dhammi; Zachary Holt; Victor Baquero; Scott MacDonald; Anthony Jerant; Ron Sprinkle; Richard L Kravitz
Journal:  Trials       Date:  2015-02-27       Impact factor: 2.279

Review 10.  Relieving pain using dose-extending placebos: a scoping review.

Authors:  Luana Colloca; Paul Enck; David DeGrazia
Journal:  Pain       Date:  2016-08       Impact factor: 7.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.